Skip to content
Annika Bansal – Lifestyle
Author:
Curonix LLC
Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden
September 28, 2026
Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions
July 23, 2026
Curonix LLC Announces Appointment of Don Payerle to its Board of Managers, Strengthening Strategic Leadership
April 9, 2026
Curonix LLC Announces Expanded Reimbursement Coverage for Freedom® Peripheral Nerve Stimulator (PNS) System, Providing Access To An Additional 27 Million Covered Lives Nationwide
April 2, 2026